Back to search results

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Acral Melanoma · Advanced Cutaneous Melanoma · Advanced Mucosal Melanoma · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Metastatic Acral Melanoma · Metastatic Cutaneous Melanoma · Metastatic Mucosal Melanoma · Unresectable Acral Melanoma · Unresectable Cutaneous Melanoma · Unresectable Mucosal Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Tiffaney Roundtree) · tiffaney.laquinta.roundtree@emory.edu
    Contact: Principal Investigator (Michael C. Lowe, MD, MA)

  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Tiffaney Roundtree) · tiffaney.laquinta.roundtree@emory.edu
    Contact: Principal Investigator (Michael C. Lowe, MD, MA)
Study leads

  • Michael Lowe, MD, MA

    Principal Investigator

    Emory University Hospital/Winship Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)